Global Immunotherapy Market Research Report 2023

Report ID: 1900874 | Published Date: Sep 2024 | No. of Page: 90 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immunotherapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Monoclonal Antibodies
        1.2.3 Therapeutic Vaccines
        1.2.4 Checkpoint Inhibitors
        1.2.5 Non-Specific Immunotherapy
    1.3 Market by Application
        1.3.1 Global Immunotherapy Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Oncology
        1.3.3 Inflammation
        1.3.4 Central Nervous System
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Immunotherapy Market Perspective (2018-2029)
    2.2 Immunotherapy Growth Trends by Region
        2.2.1 Global Immunotherapy Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Immunotherapy Historic Market Size by Region (2018-2023)
        2.2.3 Immunotherapy Forecasted Market Size by Region (2024-2029)
    2.3 Immunotherapy Market Dynamics
        2.3.1 Immunotherapy Industry Trends
        2.3.2 Immunotherapy Market Drivers
        2.3.3 Immunotherapy Market Challenges
        2.3.4 Immunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Immunotherapy Players by Revenue
        3.1.1 Global Top Immunotherapy Players by Revenue (2018-2023)
        3.1.2 Global Immunotherapy Revenue Market Share by Players (2018-2023)
    3.2 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Immunotherapy Revenue
    3.4 Global Immunotherapy Market Concentration Ratio
        3.4.1 Global Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2022
    3.5 Immunotherapy Key Players Head office and Area Served
    3.6 Key Players Immunotherapy Product Solution and Service
    3.7 Date of Enter into Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapy Breakdown Data by Type
    4.1 Global Immunotherapy Historic Market Size by Type (2018-2023)
    4.2 Global Immunotherapy Forecasted Market Size by Type (2024-2029)
5 Immunotherapy Breakdown Data by Application
    5.1 Global Immunotherapy Historic Market Size by Application (2018-2023)
    5.2 Global Immunotherapy Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Immunotherapy Market Size (2018-2029)
    6.2 North America Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Immunotherapy Market Size by Country (2018-2023)
    6.4 North America Immunotherapy Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Immunotherapy Market Size (2018-2029)
    7.2 Europe Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Immunotherapy Market Size by Country (2018-2023)
    7.4 Europe Immunotherapy Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Immunotherapy Market Size (2018-2029)
    8.2 Asia-Pacific Immunotherapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Immunotherapy Market Size by Region (2018-2023)
    8.4 Asia-Pacific Immunotherapy Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Immunotherapy Market Size (2018-2029)
    9.2 Latin America Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Immunotherapy Market Size by Country (2018-2023)
    9.4 Latin America Immunotherapy Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Immunotherapy Market Size (2018-2029)
    10.2 Middle East & Africa Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Immunotherapy Market Size by Country (2018-2023)
    10.4 Middle East & Africa Immunotherapy Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Abbvie
        11.1.1 Abbvie Company Detail
        11.1.2 Abbvie Business Overview
        11.1.3 Abbvie Immunotherapy Introduction
        11.1.4 Abbvie Revenue in Immunotherapy Business (2018-2023)
        11.1.5 Abbvie Recent Development
    11.2 Amgen, Inc.
        11.2.1 Amgen, Inc. Company Detail
        11.2.2 Amgen, Inc. Business Overview
        11.2.3 Amgen, Inc. Immunotherapy Introduction
        11.2.4 Amgen, Inc. Revenue in Immunotherapy Business (2018-2023)
        11.2.5 Amgen, Inc. Recent Development
    11.3 Biogen
        11.3.1 Biogen Company Detail
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Immunotherapy Introduction
        11.3.4 Biogen Revenue in Immunotherapy Business (2018-2023)
        11.3.5 Biogen Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Detail
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Immunotherapy Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Immunotherapy Business (2018-2023)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Celgene
        11.5.1 Celgene Company Detail
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Immunotherapy Introduction
        11.5.4 Celgene Revenue in Immunotherapy Business (2018-2023)
        11.5.5 Celgene Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Detail
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Immunotherapy Introduction
        11.6.4 Johnson & Johnson Revenue in Immunotherapy Business (2018-2023)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Immunotherapy Introduction
        11.7.4 Merck Revenue in Immunotherapy Business (2018-2023)
        11.7.5 Merck Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Immunotherapy Introduction
        11.8.4 Novartis Revenue in Immunotherapy Business (2018-2023)
        11.8.5 Novartis Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Immunotherapy Introduction
        11.9.4 Pfizer Revenue in Immunotherapy Business (2018-2023)
        11.9.5 Pfizer Recent Development
    11.10 Roche
        11.10.1 Roche Company Detail
        11.10.2 Roche Business Overview
        11.10.3 Roche Immunotherapy Introduction
        11.10.4 Roche Revenue in Immunotherapy Business (2018-2023)
        11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Immunotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Therapeutic Vaccines
    Table 4. Key Players of Checkpoint Inhibitors
    Table 5. Key Players of Non-Specific Immunotherapy
    Table 6. Global Immunotherapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Immunotherapy Market Share by Region (2018-2023)
    Table 10. Global Immunotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Immunotherapy Market Share by Region (2024-2029)
    Table 12. Immunotherapy Market Trends
    Table 13. Immunotherapy Market Drivers
    Table 14. Immunotherapy Market Challenges
    Table 15. Immunotherapy Market Restraints
    Table 16. Global Immunotherapy Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Immunotherapy Market Share by Players (2018-2023)
    Table 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)
    Table 19. Ranking of Global Top Immunotherapy Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Immunotherapy Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Immunotherapy Product Solution and Service
    Table 23. Date of Enter into Immunotherapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Immunotherapy Revenue Market Share by Type (2018-2023)
    Table 27. Global Immunotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Immunotherapy Revenue Market Share by Type (2024-2029)
    Table 29. Global Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Immunotherapy Revenue Market Share by Application (2018-2023)
    Table 31. Global Immunotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Immunotherapy Revenue Market Share by Application (2024-2029)
    Table 33. North America Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Immunotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Immunotherapy Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Abbvie Company Detail
    Table 49. Abbvie Business Overview
    Table 50. Abbvie Immunotherapy Product
    Table 51. Abbvie Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 52. Abbvie Recent Development
    Table 53. Amgen, Inc. Company Detail
    Table 54. Amgen, Inc. Business Overview
    Table 55. Amgen, Inc. Immunotherapy Product
    Table 56. Amgen, Inc. Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 57. Amgen, Inc. Recent Development
    Table 58. Biogen Company Detail
    Table 59. Biogen Business Overview
    Table 60. Biogen Immunotherapy Product
    Table 61. Biogen Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 62. Biogen Recent Development
    Table 63. Bristol-Myers Squibb Company Detail
    Table 64. Bristol-Myers Squibb Business Overview
    Table 65. Bristol-Myers Squibb Immunotherapy Product
    Table 66. Bristol-Myers Squibb Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 67. Bristol-Myers Squibb Recent Development
    Table 68. Celgene Company Detail
    Table 69. Celgene Business Overview
    Table 70. Celgene Immunotherapy Product
    Table 71. Celgene Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 72. Celgene Recent Development
    Table 73. Johnson & Johnson Company Detail
    Table 74. Johnson & Johnson Business Overview
    Table 75. Johnson & Johnson Immunotherapy Product
    Table 76. Johnson & Johnson Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 77. Johnson & Johnson Recent Development
    Table 78. Merck Company Detail
    Table 79. Merck Business Overview
    Table 80. Merck Immunotherapy Product
    Table 81. Merck Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 82. Merck Recent Development
    Table 83. Novartis Company Detail
    Table 84. Novartis Business Overview
    Table 85. Novartis Immunotherapy Product
    Table 86. Novartis Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 87. Novartis Recent Development
    Table 88. Pfizer Company Detail
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Immunotherapy Product
    Table 91. Pfizer Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 92. Pfizer Recent Development
    Table 93. Roche Company Detail
    Table 94. Roche Business Overview
    Table 95. Roche Immunotherapy Product
    Table 96. Roche Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
    Table 97. Roche Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunotherapy Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Immunotherapy Market Share by Type: 2022 VS 2029
    Figure 3. Monoclonal Antibodies Features
    Figure 4. Therapeutic Vaccines Features
    Figure 5. Checkpoint Inhibitors Features
    Figure 6. Non-Specific Immunotherapy Features
    Figure 7. Global Immunotherapy Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Immunotherapy Market Share by Application: 2022 VS 2029
    Figure 9. Oncology Case Studies
    Figure 10. Inflammation Case Studies
    Figure 11. Central Nervous System Case Studies
    Figure 12. Others Case Studies
    Figure 13. Immunotherapy Report Years Considered
    Figure 14. Global Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Immunotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Immunotherapy Market Share by Region: 2022 VS 2029
    Figure 17. Global Immunotherapy Market Share by Players in 2022
    Figure 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Immunotherapy Revenue in 2022
    Figure 20. North America Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Immunotherapy Market Share by Country (2018-2029)
    Figure 22. United States Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Immunotherapy Market Share by Country (2018-2029)
    Figure 26. Germany Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Immunotherapy Market Share by Region (2018-2029)
    Figure 34. China Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Immunotherapy Market Share by Country (2018-2029)
    Figure 42. Mexico Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Immunotherapy Market Share by Country (2018-2029)
    Figure 46. Turkey Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Abbvie Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 49. Amgen, Inc. Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 50. Biogen Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 52. Celgene Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 53. Johnson & Johnson Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 54. Merck Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 55. Novartis Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 56. Pfizer Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 57. Roche Revenue Growth Rate in Immunotherapy Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Frequently Asked Questions
Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports